These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 621753)

  • 1. Chemotherapeutic activity of new 2-chloroethylnitrosoureas in rat L5222 leukemia: comparison of bifunctional and water-soluble derivatives with 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Zeller WJ; Eisenbrand G; Fiebig HH
    J Natl Cancer Inst; 1978 Feb; 60(2):345-8. PubMed ID: 621753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some new congeners of the anticancer agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Synthesis of bifunctional analogs and water soluble derivatives and preliminary evaluation of their chemotherapeutic potential.
    Eisenbrand G; Fiebig HH; Zeller WJ
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Aug; 86(3):279-86. PubMed ID: 136102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of four newly synthesized 2-chloroethylnitrosoureas in comparison with BCNU, CCNU, MeCCNU, chlorozotocin and hydroxyethyl-CNU in preterminal rat leukemia L 5222.
    Zeller WJ; Eisenbrand G; Fiebig HH
    J Cancer Res Clin Oncol; 1979 Sep; 95(1):43-9. PubMed ID: 159309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy of the transplantable acute leukemia L5222 in rats.
    Zeller WJ; Ivankovic S; Schmähl D
    Cancer Res; 1975 May; 35(5):1168-74. PubMed ID: 1120307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic effects of some new bifunctional and water-soluble analogs of the anti-cancer agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in Saccharomyces cerevisiae.
    Siebert D; Eisenbrand G
    Mutat Res; 1977 Jan; 42(1):45-50. PubMed ID: 321953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An experimental model for meningeal leukemia in rats (L5222). Effect of treatment with BCNU and cyclophosphamide.
    Fiebig HH; Zeller WH; Schmähl D
    Int J Cancer; 1976 Nov; 18(5):710-6. PubMed ID: 992902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of newly synthesized 2-chloroethyl-nitrosoureas on rat leukemia L 5222.
    Zeller WJ; Eisenbrand G
    Oncology; 1981; 38(1):39-42. PubMed ID: 7443175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of second malignancies in rats after cure of acute leukemia L 5222 by single doses of 2-chloroethylnitrosoureas.
    Zeller WJ; Schmähl D
    J Cancer Res Clin Oncol; 1979 Sep; 95(1):83-6. PubMed ID: 227910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Water soluble derivatives and bifunctional analogs of the anticancer agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU).
    Fiebig HH; Eisenbrand G; Zeller WJ; Deutsch-Wenzel T
    Eur J Cancer (1965); 1977 Sep; 13(9):937-45. PubMed ID: 913476
    [No Abstract]   [Full Text] [Related]  

  • 10. An analysis of 1-(2-chloroethyl)-1-nitrosourea activity at the cellular level.
    Weinkam RJ; Dolan ME
    J Med Chem; 1983 Nov; 26(11):1656-9. PubMed ID: 6226795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of newly synthesized 2-chloroethylnitrosoureas in preterminal leukemia L 5222 and in two transplanted neurogenic tumors.
    Berger M; Zeller WJ; Eisenbrand G; Lin PZ; Nakra M; Schmähl D
    Arzneimittelforschung; 1982; 32(5):481-4. PubMed ID: 6285938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of new nitrosoureas on Yoshida sarcoma ascites cells implanted into the colon wall of rats.
    Habs M; Reinbold H; Eisenbrand G; Bhide S; Goga-Ionescu S; Schmähl D
    J Cancer Res Clin Oncol; 1981; 101(3):285-302. PubMed ID: 7309781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer activity of new nitrosoureas against Walder carcinosarcoma 256 and DMBA-induced mammary cancer of the rat.
    Fiebig HH; Eisenbrand G; Zeller WJ; Zentgraf R
    Oncology; 1980; 37(3):177-83. PubMed ID: 6444708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cell cycle position on the survival of 9L cells treated with nitrosoureas that alkylate, cross-link, and carbamoylate.
    Linfoot PA; Gray JW; Dean PN; Marton LJ; Deen DF
    Cancer Res; 1986 May; 46(5):2402-6. PubMed ID: 3697983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of carbamoylation on cell survival and DNA repair in normal human embryo cells (IMR-90) treated with various 1-(2-chloroethyl)-1-nitrosoureas.
    Sariban E; Erickson LC; Kohn KW
    Cancer Res; 1984 Apr; 44(4):1352-7. PubMed ID: 6704956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of uptake of nitrosoureas by L5178Y lymphoblasts in vitro.
    Begleiter A; Lam HP; Goldenberg GJ
    Cancer Res; 1977 Apr; 37(4):1022-7. PubMed ID: 557367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of nitrosoureas: comparison of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) after oral and intravenous administration to rats.
    Russo RG; Cattaneo MT; Bartosek I
    Tumori; 1984 Dec; 70(6):499-502. PubMed ID: 6531792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea, a novel chloroethylnitrosourea analogue with enhanced antitumor activity against human glioma xenografts.
    Marcantonio D; Panasci LC; Hollingshead MG; Alley MC; Camalier RF; Sausville EA; Dykes DJ; Carter CA; Malspeis L
    Cancer Res; 1997 Sep; 57(18):3895-8. PubMed ID: 9307267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth and rejection of leukemia cells in individual mice after combined treatment with amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Valeriote F; Lynch R; Medoff G; Tolen S; Dieckman J
    J Natl Cancer Inst; 1978 Aug; 61(2):399-402. PubMed ID: 277727
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.